SCM
ALT icon

Sterling Capital Management’s Altimmune ALT Stock Holding History

Sterling Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2K Buy
4,006
+3,159
+373% +$9.44K ﹤0.01% 2117
2026
Q1 		$2.61K Buy
847
+317
+60% +$1.35K ﹤0.01% 2931
2025
Q4 		$1.91K Buy
530
+333
+169% +$1.45K ﹤0.01% 3072
2025
Q3 		$743 Buy
197
+10
+5% +$39 ﹤0.01% 3120
2025
Q2 		$724 Sell
187
-412
-69% -$2.23K ﹤0.01% 3109
2025
Q1 		$3K Sell
599
-479
-44% -$3.03K ﹤0.01% 2412
2024
Q4 		$7.77K Buy
1,078
+935
+654% +$7.14K ﹤0.01% 2274
2024
Q3 		$878 Buy
+143
New +$969 ﹤0.01% 2601

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sterling Capital Management's ALT Position: Q2 2026 in Review

Sterling Capital Management increased its Altimmune (ALT) stake by 373% in Q2 2026, buying an estimated $9.44K and bringing the position to 4,006 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

Sterling Capital Management first reported a position in ALT in Q3 2024 and has held it in 8 quarters since. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Sterling Capital Management held 4,006 shares of Altimmune worth $12.2K as of Q2 2026.
  • Sterling Capital Management bought 3,159 Altimmune shares in Q2 2026, an estimated $9.44K.
  • Altimmune made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2117 holding.
  • Sterling Capital Management first reported a position in Altimmune in Q3 2024 and has held it in 8 quarters since.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.